Press Releases for South Korea
Elliott Welcomes Hyundai’s Acknowledgment of Needed Reforms Highlights Need for More Serious Action
Announces significant stake in Hyundai Mobis, Hyundai Motor, and Kia Motors Seeks stronger commitment to governance improvements and enhanced capital returns 03/04/2018 — HONG KONG — (BUSINESS WIRE) Elliott Advisors […]
Ghostbusters World with Google Maps API Featured During Google Keynote at GDC 2018
New Gameplay Preview Video Footage Shows Google Maps API in Action 19/03/2018 — SEOUL, South Korea — (BUSINESS WIRE) The recently announced Ghostbusters World, developed in collaboration between Sony Pictures […]
Alibaba Group Unveils Olympic Games Technology Showcase and Future Vision at Olympic Winter Games PyeongChang 2018
10/02/2018 — PYEONGCHANG, Korea & HANGZHOU, China — (BUSINESS WIRE) Alibaba Group (NYSE:BABA), the world’s largest retail commerce company, kicked off its first Olympic Games as a TOP partner today […]
Mobile RPG ‘King’s Raid’ Set to Launch in European Markets
22/09/2017 — SEOUL, South Korea — (BUSINESS WIRE) Mobile RPG “King’s Raid” which was launched in February in Korea, North America and SEA, is officially launching in European Markets (Google […]
Samsung Bioepis’ Flixabi® Infliximab Biosimilar Recommended for Approval in the European Union
Samsung Bioepis’ Flixabi® receives positive opinion from the Committee for Medicinal Products for Human Use, meets the European Medicines Agency’s requirements on the quality, efficacy and safety of biosimilars Flixabi® […]
Samsung Bioepis Enters the European Biopharmaceutical Market with Benepali®, the First Fusion Protein Biosimilar Approved by the European Commission
Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) approval of Benepali® – a biosimilar referencing Enbrel® (etanercept), also known as SB4 – for the treatment of rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis) and plaque psoriasis. The EC approval follows a positive opinion on Benepali® by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP), which was announced on November 20, 2015.
The Estée Lauder Companies Completes Investment in Dr. Jart+
The Estée Lauder Companies Inc. (NYSE:EL) announced today that it has completed its investment in Have & Be Co. Ltd., the South Korean company behind skin care brands Dr. Jart+ and Do The Right Thing. Terms of the investment were not disclosed. Launched online in 2005 by ChinWook Lee, Dr. Jart+ is a Seoul-based, global high-growth skin care brand featuring quality and innovative products designed to address specific skin care needs. The brand’s unique fusion of dermatological science and art – as reflected in the brand name, which is inspired by the phrase “Doctor Joins Art” – appeals to a broad range of consumers, especially millennials. Dr. Jart+ is sold in many countries around the world, primarily in Asia and the United States, through various department stores, specialty-multi and e-commerce channels including Sephora.
Samsung Bioepis’ RENFLEXIS® Infliximab Biosimilar Receives Regulatory Approval in Korea
Samsung Bioepis Co., Ltd. today announced that Korea’s Ministry of Food and Drug Safety (MFDS) has approved RENFLEXIS® – a biosimilar version of Remicade® (infliximab), also known as SB2 – for the treatment of rheumatoid arthritis, ankylosing spondylitis, Crohn’s disease, pediatric Crohn’s disease, ulcerative colitis, pediatric ulcerative colitis, psoriatic arthritis and plaque psoriasis. This marks the second regulatory approval for Samsung Bioepis in Korea. The MFDS approved in September 2015 Samsung Bioepis’ BRENZYS®, a biosimilar version of Enbrel® (etanercept), also known as SB4.
Hyundai Motor Group Realizes Internally Displaced People’s Dream
The ‘Going Home Campaign’ of 3D digital visit to North Korea continues the Hyundai’s Korean reunification project.
25/11/2015 — SEOUL, South Korea — (BUSINESS WIRE)
The video clips of Hyundai Motor Group, known to give new hope to those missing their hometown, have become a topic.
Samsung Bioepis Receives Positive CHMP Opinion for the First Etanercept Biosimilar in the European Union
Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on Benepali® – a biosimilar version of Enbrel® (etanercept), previously known as SB4 – for the treatment of rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis) and plaque psoriasis. This marks the first time the CHMP has adopted a positive opinion on an etanercept biosimilar.
18th Manufacturing World Osaka Ended with the Greatest Success!
Reed Exhibitions Japan Ltd., the largest show organiser in Japan, announced that 18th Manufacturing World Osaka held from October 7 – 9, 2015 at INTEX Osaka, the Western Japan’s largest trade show for the manufacturing industry, ended with the greatest success with 1,063 exhibitors and 42,216 visitors from around the world.
Open Interconnect Consortium Adds Members Across Industries and International Markets
Internet of Things standards body now includes Fortune 100 companies from all of the worlds regions; Announces new liaison agreements and welcomes new executive director
Monster Announces Pricing of $125 Million Offering of Convertible Senior Notes Due 2019
Monster (NYSE:MWW) today announced the pricing of an offering of $125 million aggregate principal amount of its convertible senior notes due 2019 (the notes) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the Act). Concurrently with the pricing of the notes, Monster entered into a capped call transaction with an affiliate of one of the initial purchasers. The sale of the notes is expected to close on October 22, 2014, subject to customary closing conditions.
Heartbeat Experts Reports Over 350% Year To Date Growth from the Emerging Markets
Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry, announced today 350% year-over-year growth in emerging markets in the first quarter of 2013 compared to the same period in 2012.
Southco Expands SAP ECC 6.0 System Globally under Rimini Street Support
SAP SAPPHIRE NOW 2013 Conference Rimini Street, Inc., the leading third-party maintenance and support provider for enterprise software, including SAP AG (NYSE:SAP) software and Oracle Corporations (NASDAQ: ORCL) Siebel, PeopleSoft, JD Edwards, E-Business Suite, Oracle Database and Hyperion software, today announced that Southco, a leading international provider of engineered access hardware, recently completed the initial phase of its strategic SAP global expansion while utilizing Rimini Street for support of its SAP ECC 6.0 system. Like Southco, hundreds of companies around the world are leveraging third-party support from Rimini Street to reduce total support costs by up to 90 percent while continuing to advance the scope, scale and use of its enterprise software to achieve its business objectives. As a result, many Rimini Street clients, including Southco, are able to use their significant savings from third-party support to fund important business and IT improvements that directly affect their ability to better compete in the global marketplace.
Monster Worldwide Reports First Quarter 2013 Results
Monster Worldwide, Inc. (NYSE:MWW) today reported financial results for the first quarter ended March 31, 2013. Concurrently, Monster announced that its Board of Directors has authorized the repurchase of up to $200 million of the Companys outstanding shares over a period of 24 months.
Samsung Highlights Innovations in Mobile Experiences Driven by Components, in CES Keynote
Samsung Electronics Co., Ltd., a world leader in advanced semiconductor solutions, today redefined the story of consumer electronics from its perspective beneath the surface of mobile devices at the 2013 International CES keynote address.
Global Technology Power Players Unite to Form Alliance for Wireless Power Creating Spatial Freedom in Consumer Electronics Charging
Wireless technology leaders Samsung and Qualcomm Incorporated have
joined other technology leaders to form the Alliance for Wireless Power
(A4WP), it was announced today.